

Eli Lilly and Co (LLY) Government Trades - Latest Congressional Stock Transactions
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
top performing (LLY) trades

Daniel Goldman
House (D-NY)
217.80%

Josh Gottheimer
House (D-NJ)
150.10%

John Curtis
House (R-UT)
92.30%

Dan Newhouse
House (R-WA)
77.90%

Markwayne Mullin
Senate (R-OK)
68.10%

Sheldon Whitehouse
Senate (D-RI)
68.00%

Jared Moskowitz
House (D-FL)
62.70%

Lisa McClain
House (R-MI)
55.20%

David Taylor
House (R-OH)
39.60%

Bruce Westerman
House (R-AR)
39.50%

John Boozman
Senate (R-AR)
35.30%

Marjorie Taylor Greene
House (R-GA)
30.50%

Roger Williams
House (R-TX)
18.30%

Shelley Moore Capito
Senate (R-WV)
12.70%

Jonathan Jackson
House (D-IL)
-6.80%

Greg Landsman
House (D-OH)
-15.90%
Recent Eli Lilly (LLY) Trades by Congress Members
See the most up-to-date Eli Lilly trades disclosed by US lawmakers, including purchase and sale amounts, transaction dates, and reporting details. View the most recent Eli Lilly trades made by congress members.



